Lam Research (NASDAQ:LRCX – Get Free Report) issued an update on its fourth quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.500-1.800 for the period, compared to the consensus estimate of 1.450. The company issued revenue guidance of $6.2 billion-$7.0 billion, compared to the consensus revenue estimate of $6.1 billion.
Lam Research Trading Up 0.5%
NASDAQ:LRCX traded up $1.40 during trading hours on Thursday, hitting $266.95. 1,621,000 shares of the company were exchanged, compared to its average volume of 11,158,528. The stock has a market capitalization of $333.35 billion, a price-to-earnings ratio of 54.82, a price-to-earnings-growth ratio of 2.75 and a beta of 1.78. Lam Research has a one year low of $67.55 and a one year high of $273.50. The company has a fifty day simple moving average of $233.80 and a 200 day simple moving average of $196.58. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.11. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.84 billion for the quarter, compared to analyst estimates of $5.70 billion. During the same quarter in the previous year, the company posted $1.04 EPS. The business’s revenue was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Sell-side analysts expect that Lam Research will post 5.3 EPS for the current fiscal year.
Lam Research Dividend Announcement
Analyst Ratings Changes
Several research firms have issued reports on LRCX. Weiss Ratings restated a “buy (b-)” rating on shares of Lam Research in a report on Friday, April 10th. Argus lifted their target price on shares of Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. Morgan Stanley upped their price target on shares of Lam Research from $254.00 to $260.00 and gave the company an “equal weight” rating in a research report on Monday, April 6th. Barclays set a $275.00 price target on Lam Research in a report on Thursday. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $320.00 price objective (up from $265.00) on shares of Lam Research in a research note on Thursday, January 29th. Twenty-seven research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $273.60.
Read Our Latest Analysis on LRCX
Insider Buying and Selling
In related news, insider Ava Harter sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.50, for a total transaction of $930,000.00. Following the transaction, the insider directly owned 54,705 shares of the company’s stock, valued at approximately $12,718,912.50. This represents a 6.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Douglas R. Bettinger sold 50,057 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the sale, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is owned by company insiders.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam reported fiscal Q3 results above estimates — $1.47 non-GAAP EPS vs. $1.36 consensus and $5.84B revenue (up 23.8% YoY). The release highlights record revenue and improved margins that underpinned the rally. PR Newswire
- Positive Sentiment: Management raised FYQ4 guidance: EPS $1.50–1.80 and revenue guidance midpoint (~$6.6B) came in above street expectations, signaling continued WFE strength. That upside to guidance is a primary driver of the rally. MarketBeat — Earnings
- Positive Sentiment: AI-driven chip demand is cited repeatedly as the demand engine — analysts and press note expanding spending on AI logic and memory fabs is lifting orders and margins for Lam’s etch/dep tools. Globe and Mail — Deep Dive
- Positive Sentiment: Wall Street raised targets and reiterated buys after the beat — examples include Needham ($300), BofA ($330) and TD Cowen ($340) — adding momentum as analysts push valuation higher. TipRanks — Ratings
- Neutral Sentiment: The company’s earnings call transcript and slide deck are available for investors digging into product-level demand, backlog and capex cadence. Seeking Alpha — Call Transcript
- Neutral Sentiment: Lam is named as a supplier for large-scale projects (e.g., Tesla Terafab), which supports long-duration revenue potential but requires execution and timelines to play out. Barchart — Terafab
- Negative Sentiment: Some commentators warn LRCX faces an earnings “test” after a sharp pre-report rally; elevated valuation metrics (P/E >50) mean expectations are high and leave limited room for disappointment. Seeking Alpha — Caution
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in LRCX. Brighton Jones LLC lifted its position in Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after acquiring an additional 12,936 shares in the last quarter. Caxton Associates LLP purchased a new position in shares of Lam Research during the first quarter valued at approximately $239,000. Gabelli Funds LLC bought a new stake in Lam Research during the second quarter worth $253,000. NewEdge Advisors LLC raised its position in Lam Research by 2.7% in the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after buying an additional 2,661 shares during the last quarter. Finally, Osterweis Capital Management Inc. lifted its stake in Lam Research by 5,206.7% during the 2nd quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock valued at $77,000 after acquiring an additional 781 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
